<section id ="1126459-1130958" class="mfp-hide modal-dialog modal-content overlay-def"><header class="modal-header"><h2 class="modal-title">SOR/2019-121, s. 1</h2></header><div class="modal-body"><p class="Section amending" id="1126459"><strong><a class="sectionLabel" id="s-1"><span class="sectionLabel">1</span></a></strong> Item 16 of Schedule I to the <cite class="XRefExternalAct">Controlled Drugs and Substances Act</cite><a href="#fn_81200-2-462_hq_23706" id="fn_81200-2-462_hq_23706-ID0EBCA"><span class="wb-invisible">Footnote </span><sup>1</sup></a> is amended by adding the following after subitem (13):</p><ul class="ProvisionList"><li><div class="Footnote"><p class="Footnote"><a href="#fn_81200-2-462_hq_23706-ID0EBCA" id="fn_81200-2-462_hq_23706"><span class="wb-invisible">Return to footnote </span><sup>1</sup></a>S.C. 1996, c. 19</p></div></li></ul><section><div class="AmendedText"><figure><ul class="noBullet"><li><div class="listItemBlock0"><div class="listItemLabel"><span class="lawlabel">(14)</span> </div><div class="listItemText2">4-Anilino-N-phenethylpiperidine (ANPP) (N-phenyl-1-(2-phenylethyl)piperidine-4-amine), its derivatives and analogues and salts of derivatives and analogues</div></div></li></ul></figure></div></section></div></section>